FlyteHealth Selected for CMS ACCESS Model to Advance Cardio-Kidney-Metabolic Care

FlyteHealth, a precision cardio-kidney-metabolic care provider, has been recognized by the Centers for Medicare & Medicaid Services (CMS) in preparation for the ACCESS Model, a 10-year Medicare payment demonstration launching in July 2026. The ACCESS Model aims to improve chronic care outcomes for conditions such as hypertension, dyslipidemia, obesity, central adiposity, and prediabetes—key contributors to cardiovascular diseases, kidney failure, and diabetes. FlyteHealth's integrated virtual care model targets these upstream health drivers through a dual approach: Precision Lifestyle Management utilizing AI-enabled tools and remote monitoring for personalized behavioral interventions, and Expert Clinical & Medication Management focused on personalized care plans and medication optimization. Their multidisciplinary clinical team, including CHWs, MDs, NPs, and RNs, deliver care that has resulted in significant clinical improvements across cardio-kidney-metabolic risk factors. Evidence supporting FlyteHealth's impact includes notable reductions in blood pressure, LDL, HbA1c levels, and sustained weight loss over 24 months, alongside high medication adherence rates validated by pharmacy claims. This model is particularly suited for the Medicare population aged 65 and over, aligning with the ACCESS program's goals to enhance chronic disease management through scalable and technology-driven solutions. FlyteHealth's approach integrates AI-powered clinical intelligence with decision-support tools to optimize medication value and reduce total cost of care for cardiometabolic diseases nationwide.